Low BDNF levels detected during early-stage in Parkinson's disease (PD) [10], Huntington's disease (HD) [11], Alzheimer’s Disease (AD), and multiple sclerosis (MS) [12] may be associated with underlying pathogenic mechanisms. This evidence concerns the gene BDNF and Parkinson disease.